Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 27, 2009View

Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell Carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

EJEric JonaschThe University of Texas MD Anderson Cancer CenterCWChristopher G. WoodMassachusetts Eye and Ear InfirmarySMSurena F. MatinCleveland Clinic

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jonasch et al. (2009) studied this question.

synapsesocial.com/papers/69dd63ebc5e71f7918100e85https://doi.org/10.1200/jco.2008.21.3660
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phase II Trial of Weekly Intravenous Gemcitabine With Continuous Infusion Fluorouracil in Patients With Metastatic Renal Cell Cancer2000 · 155 citations
  2. 2Prospective Randomized Trial of Interferon Alfa-2a Plus Vinblastine Versus Vinblastine Alone in Patients With Advanced Renal Cell Cancer1999 · 444 citations
  3. 3Cancer Statistics, 20072007 · 7,474 citations
  4. 4Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases2008 · 118 citations
  5. 5Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma2004 · 824 citations